Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug By Jonathan Stempel NEW YORK – A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to avoid payments…